The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Valganciclovir is an antiviral. It is used to treat infections caused by viruses. This medicine is also used to prevent CMV disease in patients who have received an organ transplant (eg, heart, kidney, or kidney-pancreas transplant).
The global Valganciclovir market was valued at US$ 218 million in 2023 and is anticipated to reach US$ 325.4 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
On the basis of region, the valganciclovir market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the valganciclovir market. This can be attributed to the rising prevalence of Valganciclovir-resistant cytomegalovirus (CMV) and the increasing demand for oral drugs in this region. Latin America is projected to grow at a significant rate during the forecast period owing to the rising prevalence of Valganciclovir-resistant cytomegalovirus (CMV) and the increasing demand for oral drugs in this region.
This report aims to provide a comprehensive presentation of the global market for Valganciclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valganciclovir.
Report Scope
The Valganciclovir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valganciclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valganciclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Rakshit Drugs
- United Biotech Private Limited
- Roche
Segment by Type
- Powder
- Tablet
Segment by Application
- Adults
- Children
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valganciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valganciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Valganciclovir Market Overview
1.1 Product Overview and Scope of Valganciclovir
1.2 Valganciclovir Segment by Type
1.2.1 Global Valganciclovir Market Value Comparison by Type (2024-2030)
1.2.2 Powder
1.2.3 Tablet
1.3 Valganciclovir Segment by Application
1.3.1 Global Valganciclovir Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Valganciclovir Market Size Estimates and Forecasts
1.4.1 Global Valganciclovir Revenue 2019-2030
1.4.2 Global Valganciclovir Sales 2019-2030
1.4.3 Global Valganciclovir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valganciclovir Market Competition by Manufacturers
2.1 Global Valganciclovir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valganciclovir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valganciclovir Average Price by Manufacturers (2019-2024)
2.4 Global Valganciclovir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valganciclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valganciclovir, Product Type & Application
2.7 Valganciclovir Market Competitive Situation and Trends
2.7.1 Valganciclovir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valganciclovir Players Market Share by Revenue
2.7.3 Global Valganciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valganciclovir Retrospective Market Scenario by Region
3.1 Global Valganciclovir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valganciclovir Global Valganciclovir Sales by Region: 2019-2030
3.2.1 Global Valganciclovir Sales by Region: 2019-2024
3.2.2 Global Valganciclovir Sales by Region: 2025-2030
3.3 Global Valganciclovir Global Valganciclovir Revenue by Region: 2019-2030
3.3.1 Global Valganciclovir Revenue by Region: 2019-2024
3.3.2 Global Valganciclovir Revenue by Region: 2025-2030
3.4 North America Valganciclovir Market Facts & Figures by Country
3.4.1 North America Valganciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valganciclovir Sales by Country (2019-2030)
3.4.3 North America Valganciclovir Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valganciclovir Market Facts & Figures by Country
3.5.1 Europe Valganciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valganciclovir Sales by Country (2019-2030)
3.5.3 Europe Valganciclovir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valganciclovir Market Facts & Figures by Country
3.6.1 Asia Pacific Valganciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valganciclovir Sales by Country (2019-2030)
3.6.3 Asia Pacific Valganciclovir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valganciclovir Market Facts & Figures by Country
3.7.1 Latin America Valganciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valganciclovir Sales by Country (2019-2030)
3.7.3 Latin America Valganciclovir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valganciclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Valganciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valganciclovir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valganciclovir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Valganciclovir Sales by Type (2019-2030)
4.1.1 Global Valganciclovir Sales by Type (2019-2024)
4.1.2 Global Valganciclovir Sales by Type (2025-2030)
4.1.3 Global Valganciclovir Sales Market Share by Type (2019-2030)
4.2 Global Valganciclovir Revenue by Type (2019-2030)
4.2.1 Global Valganciclovir Revenue by Type (2019-2024)
4.2.2 Global Valganciclovir Revenue by Type (2025-2030)
4.2.3 Global Valganciclovir Revenue Market Share by Type (2019-2030)
4.3 Global Valganciclovir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Valganciclovir Sales by Application (2019-2030)
5.1.1 Global Valganciclovir Sales by Application (2019-2024)
5.1.2 Global Valganciclovir Sales by Application (2025-2030)
5.1.3 Global Valganciclovir Sales Market Share by Application (2019-2030)
5.2 Global Valganciclovir Revenue by Application (2019-2030)
5.2.1 Global Valganciclovir Revenue by Application (2019-2024)
5.2.2 Global Valganciclovir Revenue by Application (2025-2030)
5.2.3 Global Valganciclovir Revenue Market Share by Application (2019-2030)
5.3 Global Valganciclovir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Rakshit Drugs
6.1.1 Rakshit Drugs Corporation Information
6.1.2 Rakshit Drugs Description and Business Overview
6.1.3 Rakshit Drugs Valganciclovir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Rakshit Drugs Valganciclovir Product Portfolio
6.1.5 Rakshit Drugs Recent Developments/Updates
6.2 United Biotech Private Limited
6.2.1 United Biotech Private Limited Corporation Information
6.2.2 United Biotech Private Limited Description and Business Overview
6.2.3 United Biotech Private Limited Valganciclovir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 United Biotech Private Limited Valganciclovir Product Portfolio
6.2.5 United Biotech Private Limited Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Valganciclovir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Valganciclovir Product Portfolio
6.3.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valganciclovir Industry Chain Analysis
7.2 Valganciclovir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valganciclovir Production Mode & Process
7.4 Valganciclovir Sales and Marketing
7.4.1 Valganciclovir Sales Channels
7.4.2 Valganciclovir Distributors
7.5 Valganciclovir Customers
8 Valganciclovir Market Dynamics
8.1 Valganciclovir Industry Trends
8.2 Valganciclovir Market Drivers
8.3 Valganciclovir Market Challenges
8.4 Valganciclovir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
